Search Knowledge Base

1 result for "famotidine"

Pharmacological interventions for prevention of weight gain in people with schizophrenia pubmed_article
Evidence Source 2022 PMID: 36190739

Evidence Search Results semantic · quality-ranked

Folic Acid and Autism: A Systematic Review of the Current State of Knowledge systematic_review pubmed_article
Quality: 52 2021 PMID: 34440744 DOI: 10.3390/cells10081976
Methotrexate for maintenance of remission in Crohn's disease systematic_review pubmed_article
Quality: 66 2014 PMID: 25157445 DOI: 10.1002/14651858.CD006884.pub3
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults rct pubmed_article
Quality: 49 2019 PMID: 31278280 DOI: 10.1038/s41598-019-46120-z
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures rct pubmed_article
Quality: 49 2019 PMID: 31412242 DOI: 10.1016/j.celrep.2019.07.043
Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin rct pubmed_article
Quality: 49 2023 PMID: 36515353 DOI: 10.1111/acel.13754
Pharmacological interventions for prevention of weight gain in people with schizophrenia meta_analysis pubmed_article
Quality: 74 2022 PMID: 36190739 DOI: 10.1002/14651858.CD013337.pub2
**Agarwal et al., 2022** | Cochrane Database Syst Rev | Meta Analysis Agarwal Sri Mahavir, Stogios Nicolette, ... Hahn Margaret. Pharmacological interventions for prevention of weight gain in people w...
SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth clinical_trial clinical_trial
Quality: 44 2022 NCT: NCT05752955
Galantamine for Alzheimer's disease systematic_review pubmed_article
Quality: 53 2001 PMID: 11279727
Drug treatment for facioscapulohumeral muscular dystrophy systematic_review pubmed_article
Quality: 51 2004 PMID: 15106171
Dalzanemdor (SAGE-718), a novel, investigational N-methyl-D-aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose-finding studies in healthy participants and an open-label study in participants with Huntington's disease. rct pubmed_article
Quality: 53 PMID: 38988035 DOI: 10.1111/cts.13852

View full evidence search →